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There are two major divisions of the human immune system: the adaptive and the innate 
immune systems. The adaptive immune responses are directed against specific pathogens 
and are essential for control and elimination of pathogens following infection. However, 
the response requires several days to occur. The innate immune system serves to prevent 
establishment of infection and protect an individual prior to development of adaptive 
immune responses. This response is immediate, directed against broad classes of 
pathogens rather than a specific organism, and is usually sufficient to prevent 
establishment of infection. Additionally, the nature of the innate immune response will 
direct and shape adaptive immune responses against invading pathogens. Contact with 
pathogenic organisms frequently occurs in mucosal tissues lining the body cavities such 
as the respiratory tract, the gastrointestinal tract, or the reproductive tract. These surfaces 
are composed of epithelial cells that act as a barrier to pathogen entry into the body and 
act as sentinel cells, alerting the immune system to the presence of an invading pathogen 
by initiating innate immune responses to pathogen. The human reproductive tract is 
exposed to a variety of sexually transmitted pathogens including Human 
Immunodeficiency Virus (HIV), Herpes Simplex Virus (HSV), and Human Papilloma 
Virus (HPV). These viruses are the cause of vast global human health and reproductive 
problems. Currently, there is a need to develop vaccines and treatment strategies to 
prevent transmission of these viruses. This study examines a cellular protein known as 
Toll-like receptor 3 (TLR3) that is involved in detecting viral pathogens and initiating 
innate antiviral immune responses to these viral pathogens. We have found that TLR3 is 
expressed by endometrial epithelial cells in the human uterus, and that expression levels 
are altered with progression through the menstrual cycle. TLR3 expression peaked during 
the secretory phase of the menstrual cycle, when the uterus is prepared for embryo 
implantation, and was dramatically decreased during menstruation until ovulation, when 
TLR3 expression levels again begin to increase. Stimulation of TLR3 with its cognitive 
ligand initiates antiviral responses by endometrial epithelial cells and epithelial cell 
secretion of natural antimicrobial peptides. These data indicate that antiviral responses in 
the human uterus can be mediated by TLR3 and may be regulated across the menstrual 
cycle, indicating that susceptibility to viral infection may be altered at different stages of 
the menstrual cycle. These results suggest that TLR3 ligands may be utilized in 
development of treatment and vaccine strategies against viral pathogens of the 
reproductive tract. 
